| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |